中文 | English
Return
Total: 104 , 1/11
Show Home Prev Next End page: GO
Author:(Yu Zhen DAI)

1.Analysis of the expression of matrix metaUoproteinase and tissue inhibitor of metalloproteinase in gestational trophoblastic diseases

Shu-Zhen DAI ; Ling-Zhi WANG ; Yu-Jun LI ;

Chinese Journal of General Practitioners 2003;0(03):-

2.Expressions of Let-7 in Normal Breast Tissue and Breast Cancer Tissue

Zhen YU ; Mingyao XIAO ; Ming CUI ; Min LIU ; Shuying DAI ; Ying CHEN ; Yuefeng HE

Journal of Kunming Medical University 2016;37(7):19-21

3.A clinical controlled study of mesh and non-mesh technique in laparoscopic repair of large hiatal hernias

Xiangyu SUN ; Yu WU ; Hongzhi ZHAO ; Zhenyu WANG ; Zhen CHEN ; Qili DAI ; Qing WANG ; Mingfang QIN

Chinese Journal of Digestive Endoscopy 2017;34(5):350-353

5.Ultrasonographic characteristics of ovarian carcinosarcoma.

Na SU ; Yu-xin JIANG ; Qing DAI ; Zhen-hong QI

Acta Academiae Medicinae Sinicae 2010;32(1):113-115

6.Effect of asymmetric dimethylarginine on platelet-aggregation and losartan intervention in spontaneous hypertensive rat models.

Ke XIA ; Dai LI ; Zhen-yu ZHAO ; Tian-lun YANG

Journal of Central South University(Medical Sciences) 2006;31(5):645-654

7.Value of ultrasonography in the diagnosis and differential diagnosis of testicular tumor.

Wei WANG ; Zhen-hua GONG ; Yu-tian DAI

National Journal of Andrology 2007;13(5):424-427

9.Time-series analysis on the acute mortality affected by air pollution, in the city of Guangzhou, 2004-2008

Xiao-Liang HUANG ; Ling-Zhen DAI ; Ping LU ; Yu SHANG ; Yi LI ; Ye-Bin TAO ; Wei HUANG

Chinese Journal of Epidemiology 2012;33(2):210-214

10.Investigation on the migration and biologic effects of nano FeOx powders under the exposure of extremely low frequency altering electric magnetic field in human heptoma-bearing nude mice in vivo.

Hui-Xiang JU ; Zhen-Yu DAI ; Ming-Zhong SUN

Chinese Journal of Hepatology 2011;19(8):594-598

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 104 , 1/11 Show Home Prev Next End page: GO